TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Genomics In Cancer Care Market Insights, Forecast to 2028

Global Genomics In Cancer Care Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 21 July 2022
  • Pages :116
  • Formats:
  • Report Code:SMR-7221840
OfferClick for best price

Best Price: $3920

Genomics In Cancer Care Market Size, Share 2022


Market Analysis and Insights: Global Genomics In Cancer Care Market

The global Genomics In Cancer Care market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genomics In Cancer Care market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genomics In Cancer Care market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genomics In Cancer Care market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genomics In Cancer Care market.

Global Genomics In Cancer Care Scope and Market Size

Genomics In Cancer Care market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Genomics In Cancer Care market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Instruments

Consumables

Services

Segment by Application

Diagnostics

Personalized Medicine

Drug Discovery

Development

Research

By Company

Illumina

Thermo Fisher scientific

Agilent

Roche

Cancer Genetics

Beckman Coulter

Bio-Rad

Danaher

Sigma Aldrich

Pacific Biosciences

Quest Diagnostics

Luminex

Oxford Gene Technology

PerkinElmer

Qiagen

GE Healthcare

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Genomics In Cancer Care product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Genomics In Cancer Care, with price, sales, revenue, and global market share of Genomics In Cancer Care from 2019 to 2022.

Chapter 3, the Genomics In Cancer Care competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Genomics In Cancer Care breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Genomics In Cancer Care market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Genomics In Cancer Care.

Chapter 13, 14, and 15, to describe Genomics In Cancer Care sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Genomics In Cancer Care Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Genomics In Cancer Care Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 116 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics In Cancer Care Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Instruments
1.2.3 Consumables
1.2.4 Services
1.3 Market by Application
1.3.1 Global Genomics In Cancer Care Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostics
1.3.3 Personalized Medicine
1.3.4 Drug Discovery
1.3.5 Development
1.3.6 Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Genomics In Cancer Care Market Perspective (2017-2028)
2.2 Genomics In Cancer Care Growth Trends by Region
2.2.1 Genomics In Cancer Care Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Genomics In Cancer Care Historic Market Size by Region (2017-2022)
2.2.3 Genomics In Cancer Care Forecasted Market Size by Region (2023-2028)
2.3 Genomics In Cancer Care Market Dynamics
2.3.1 Genomics In Cancer Care Industry Trends
2.3.2 Genomics In Cancer Care Market Drivers
2.3.3 Genomics In Cancer Care Market Challenges
2.3.4 Genomics In Cancer Care Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomics In Cancer Care Players by Revenue
3.1.1 Global Top Genomics In Cancer Care Players by Revenue (2017-2022)
3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2017-2022)
3.2 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genomics In Cancer Care Revenue
3.4 Global Genomics In Cancer Care Market Concentration Ratio
3.4.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2021
3.5 Genomics In Cancer Care Key Players Head office and Area Served
3.6 Key Players Genomics In Cancer Care Product Solution and Service
3.7 Date of Enter into Genomics In Cancer Care Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics In Cancer Care Breakdown Data by Type
4.1 Global Genomics In Cancer Care Historic Market Size by Type (2017-2022)
4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2023-2028)
5 Genomics In Cancer Care Breakdown Data by Application
5.1 Global Genomics In Cancer Care Historic Market Size by Application (2017-2022)
5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Genomics In Cancer Care Market Size (2017-2028)
6.2 North America Genomics In Cancer Care Market Size by Type
6.2.1 North America Genomics In Cancer Care Market Size by Type (2017-2022)
6.2.2 North America Genomics In Cancer Care Market Size by Type (2023-2028)
6.2.3 North America Genomics In Cancer Care Market Share by Type (2017-2028)
6.3 North America Genomics In Cancer Care Market Size by Application
6.3.1 North America Genomics In Cancer Care Market Size by Application (2017-2022)
6.3.2 North America Genomics In Cancer Care Market Size by Application (2023-2028)
6.3.3 North America Genomics In Cancer Care Market Share by Application (2017-2028)
6.4 North America Genomics In Cancer Care Market Size by Country
6.4.1 North America Genomics In Cancer Care Market Size by Country (2017-2022)
6.4.2 North America Genomics In Cancer Care Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Genomics In Cancer Care Market Size (2017-2028)
7.2 Europe Genomics In Cancer Care Market Size by Type
7.2.1 Europe Genomics In Cancer Care Market Size by Type (2017-2022)
7.2.2 Europe Genomics In Cancer Care Market Size by Type (2023-2028)
7.2.3 Europe Genomics In Cancer Care Market Share by Type (2017-2028)
7.3 Europe Genomics In Cancer Care Market Size by Application
7.3.1 Europe Genomics In Cancer Care Market Size by Application (2017-2022)
7.3.2 Europe Genomics In Cancer Care Market Size by Application (2023-2028)
7.3.3 Europe Genomics In Cancer Care Market Share by Application (2017-2028)
7.4 Europe Genomics In Cancer Care Market Size by Country
7.4.1 Europe Genomics In Cancer Care Market Size by Country (2017-2022)
7.4.2 Europe Genomics In Cancer Care Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomics In Cancer Care Market Size (2017-2028)
8.2 Asia-Pacific Genomics In Cancer Care Market Size by Type
8.2.1 Asia-Pacific Genomics In Cancer Care Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Genomics In Cancer Care Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Genomics In Cancer Care Market Share by Type (2017-2028)
8.3 Asia-Pacific Genomics In Cancer Care Market Size by Application
8.3.1 Asia-Pacific Genomics In Cancer Care Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Genomics In Cancer Care Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Genomics In Cancer Care Market Share by Application (2017-2028)
8.4 Asia-Pacific Genomics In Cancer Care Market Size by Region
8.4.1 Asia-Pacific Genomics In Cancer Care Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Genomics In Cancer Care Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Genomics In Cancer Care Market Size (2017-2028)
9.2 Latin America Genomics In Cancer Care Market Size by Type
9.2.1 Latin America Genomics In Cancer Care Market Size by Type (2017-2022)
9.2.2 Latin America Genomics In Cancer Care Market Size by Type (2023-2028)
9.2.3 Latin America Genomics In Cancer Care Market Share by Type (2017-2028)
9.3 Latin America Genomics In Cancer Care Market Size by Application
9.3.1 Latin America Genomics In Cancer Care Market Size by Application (2017-2022)
9.3.2 Latin America Genomics In Cancer Care Market Size by Application (2023-2028)
9.3.3 Latin America Genomics In Cancer Care Market Share by Application (2017-2028)
9.4 Latin America Genomics In Cancer Care Market Size by Country
9.4.1 Latin America Genomics In Cancer Care Market Size by Country (2017-2022)
9.4.2 Latin America Genomics In Cancer Care Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomics In Cancer Care Market Size (2017-2028)
10.2 Middle East & Africa Genomics In Cancer Care Market Size by Type
10.2.1 Middle East & Africa Genomics In Cancer Care Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Genomics In Cancer Care Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Genomics In Cancer Care Market Share by Type (2017-2028)
10.3 Middle East & Africa Genomics In Cancer Care Market Size by Application
10.3.1 Middle East & Africa Genomics In Cancer Care Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Genomics In Cancer Care Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Genomics In Cancer Care Market Share by Application (2017-2028)
10.4 Middle East & Africa Genomics In Cancer Care Market Size by Country
10.4.1 Middle East & Africa Genomics In Cancer Care Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Genomics In Cancer Care Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Genomics In Cancer Care Introduction
11.1.4 Illumina Revenue in Genomics In Cancer Care Business (2017-2022)
11.1.5 Illumina Recent Developments
11.2 Thermo Fisher scientific
11.2.1 Thermo Fisher scientific Company Details
11.2.2 Thermo Fisher scientific Business Overview
11.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
11.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2017-2022)
11.2.5 Thermo Fisher scientific Recent Developments
11.3 Agilent
11.3.1 Agilent Company Details
11.3.2 Agilent Business Overview
11.3.3 Agilent Genomics In Cancer Care Introduction
11.3.4 Agilent Revenue in Genomics In Cancer Care Business (2017-2022)
11.3.5 Agilent Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Genomics In Cancer Care Introduction
11.4.4 Roche Revenue in Genomics In Cancer Care Business (2017-2022)
11.4.5 Roche Recent Developments
11.5 Cancer Genetics
11.5.1 Cancer Genetics Company Details
11.5.2 Cancer Genetics Business Overview
11.5.3 Cancer Genetics Genomics In Cancer Care Introduction
11.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2017-2022)
11.5.5 Cancer Genetics Recent Developments
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Details
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Genomics In Cancer Care Introduction
11.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2017-2022)
11.6.5 Beckman Coulter Recent Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Genomics In Cancer Care Introduction
11.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2017-2022)
11.7.5 Bio-Rad Recent Developments
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Genomics In Cancer Care Introduction
11.8.4 Danaher Revenue in Genomics In Cancer Care Business (2017-2022)
11.8.5 Danaher Recent Developments
11.9 Sigma Aldrich
11.9.1 Sigma Aldrich Company Details
11.9.2 Sigma Aldrich Business Overview
11.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
11.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2017-2022)
11.9.5 Sigma Aldrich Recent Developments
11.10 Pacific Biosciences
11.10.1 Pacific Biosciences Company Details
11.10.2 Pacific Biosciences Business Overview
11.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
11.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2017-2022)
11.10.5 Pacific Biosciences Recent Developments
11.11 Quest Diagnostics
11.11.1 Quest Diagnostics Company Details
11.11.2 Quest Diagnostics Business Overview
11.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
11.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2017-2022)
11.11.5 Quest Diagnostics Recent Developments
11.12 Luminex
11.12.1 Luminex Company Details
11.12.2 Luminex Business Overview
11.12.3 Luminex Genomics In Cancer Care Introduction
11.12.4 Luminex Revenue in Genomics In Cancer Care Business (2017-2022)
11.12.5 Luminex Recent Developments
11.13 Oxford Gene Technology
11.13.1 Oxford Gene Technology Company Details
11.13.2 Oxford Gene Technology Business Overview
11.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
11.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2017-2022)
11.13.5 Oxford Gene Technology Recent Developments
11.14 PerkinElmer
11.14.1 PerkinElmer Company Details
11.14.2 PerkinElmer Business Overview
11.14.3 PerkinElmer Genomics In Cancer Care Introduction
11.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2017-2022)
11.14.5 PerkinElmer Recent Developments
11.15 Qiagen
11.15.1 Qiagen Company Details
11.15.2 Qiagen Business Overview
11.15.3 Qiagen Genomics In Cancer Care Introduction
11.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2017-2022)
11.15.5 Qiagen Recent Developments
11.16 GE Healthcare
11.16.1 GE Healthcare Company Details
11.16.2 GE Healthcare Business Overview
11.16.3 GE Healthcare Genomics In Cancer Care Introduction
11.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2017-2022)
11.16.5 GE Healthcare Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Instruments
Table 3. Key Players of Consumables
Table 4. Key Players of Services
Table 5. Global Genomics In Cancer Care Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Genomics In Cancer Care Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Genomics In Cancer Care Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Genomics In Cancer Care Market Share by Region (2017-2022)
Table 9. Global Genomics In Cancer Care Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Genomics In Cancer Care Market Share by Region (2023-2028)
Table 11. Genomics In Cancer Care Market Trends
Table 12. Genomics In Cancer Care Market Drivers
Table 13. Genomics In Cancer Care Market Challenges
Table 14. Genomics In Cancer Care Market Restraints
Table 15. Global Genomics In Cancer Care Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Genomics In Cancer Care Revenue Share by Players (2017-2022)
Table 17. Global Top Genomics In Cancer Care by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2021)
Table 18. Ranking of Global Top Genomics In Cancer Care Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Genomics In Cancer Care Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Genomics In Cancer Care Product Solution and Service
Table 22. Date of Enter into Genomics In Cancer Care Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genomics In Cancer Care Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Genomics In Cancer Care Revenue Market Share by Type (2017-2022)
Table 26. Global Genomics In Cancer Care Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Genomics In Cancer Care Revenue Market Share by Type (2023-2028)
Table 28. Global Genomics In Cancer Care Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Genomics In Cancer Care Revenue Share by Application (2017-2022)
Table 30. Global Genomics In Cancer Care Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Genomics In Cancer Care Revenue Share by Application (2023-2028)
Table 32. North America Genomics In Cancer Care Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Genomics In Cancer Care Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Genomics In Cancer Care Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Genomics In Cancer Care Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Genomics In Cancer Care Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Genomics In Cancer Care Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Genomics In Cancer Care Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Genomics In Cancer Care Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Genomics In Cancer Care Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Genomics In Cancer Care Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Genomics In Cancer Care Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Genomics In Cancer Care Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Genomics In Cancer Care Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Genomics In Cancer Care Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Genomics In Cancer Care Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Genomics In Cancer Care Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Genomics In Cancer Care Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Genomics In Cancer Care Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Genomics In Cancer Care Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Genomics In Cancer Care Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Genomics In Cancer Care Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Genomics In Cancer Care Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Genomics In Cancer Care Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Genomics In Cancer Care Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Genomics In Cancer Care Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Genomics In Cancer Care Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Genomics In Cancer Care Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Genomics In Cancer Care Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Genomics In Cancer Care Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Genomics In Cancer Care Market Size by Country (2023-2028) & (US$ Million)
Table 62. Illumina Company Details
Table 63. Illumina Business Overview
Table 64. Illumina Genomics In Cancer Care Product
Table 65. Illumina Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 66. Illumina Recent Developments
Table 67. Thermo Fisher scientific Company Details
Table 68. Thermo Fisher scientific Business Overview
Table 69. Thermo Fisher scientific Genomics In Cancer Care Product
Table 70. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 71. Thermo Fisher scientific Recent Developments
Table 72. Agilent Company Details
Table 73. Agilent Business Overview
Table 74. Agilent Genomics In Cancer Care Product
Table 75. Agilent Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 76. Agilent Recent Developments
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Genomics In Cancer Care Product
Table 80. Roche Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 81. Roche Recent Developments
Table 82. Cancer Genetics Company Details
Table 83. Cancer Genetics Business Overview
Table 84. Cancer Genetics Genomics In Cancer Care Product
Table 85. Cancer Genetics Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 86. Cancer Genetics Recent Developments
Table 87. Beckman Coulter Company Details
Table 88. Beckman Coulter Business Overview
Table 89. Beckman Coulter Genomics In Cancer Care Product
Table 90. Beckman Coulter Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 91. Beckman Coulter Recent Developments
Table 92. Bio-Rad Company Details
Table 93. Bio-Rad Business Overview
Table 94. Bio-Rad Genomics In Cancer Care Product
Table 95. Bio-Rad Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 96. Bio-Rad Recent Developments
Table 97. Danaher Company Details
Table 98. Danaher Business Overview
Table 99. Danaher Genomics In Cancer Care Product
Table 100. Danaher Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 101. Danaher Recent Developments
Table 102. Sigma Aldrich Company Details
Table 103. Sigma Aldrich Business Overview
Table 104. Sigma Aldrich Genomics In Cancer Care Product
Table 105. Sigma Aldrich Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 106. Sigma Aldrich Recent Developments
Table 107. Pacific Biosciences Company Details
Table 108. Pacific Biosciences Business Overview
Table 109. Pacific Biosciences Genomics In Cancer Care Product
Table 110. Pacific Biosciences Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 111. Pacific Biosciences Recent Developments
Table 112. Quest Diagnostics Company Details
Table 113. Quest Diagnostics Business Overview
Table 114. Quest Diagnostics Genomics In Cancer Care Product
Table 115. Quest Diagnostics Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 116. Quest Diagnostics Recent Developments
Table 117. Luminex Company Details
Table 118. Luminex Business Overview
Table 119. Luminex Genomics In Cancer Care Product
Table 120. Luminex Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 121. Luminex Recent Developments
Table 122. Oxford Gene Technology Company Details
Table 123. Oxford Gene Technology Business Overview
Table 124. Oxford Gene Technology Genomics In Cancer Care Product
Table 125. Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 126. Oxford Gene Technology Recent Developments
Table 127. PerkinElmer Company Details
Table 128. PerkinElmer Business Overview
Table 129. PerkinElmer Genomics In Cancer Care Product
Table 130. PerkinElmer Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 131. PerkinElmer Recent Developments
Table 132. Qiagen Company Details
Table 133. Qiagen Business Overview
Table 134. Qiagen Genomics In Cancer Care Product
Table 135. Qiagen Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 136. Qiagen Recent Developments
Table 137. GE Healthcare Company Details
Table 138. GE Healthcare Business Overview
Table 139. GE Healthcare Genomics In Cancer Care Product
Table 140. GE Healthcare Revenue in Genomics In Cancer Care Business (2017-2022) & (US$ Million)
Table 141. GE Healthcare Recent Developments
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Genomics In Cancer Care Market Share by Type: 2021 VS 2028
Figure 2. Instruments Features
Figure 3. Consumables Features
Figure 4. Services Features
Figure 5. Global Genomics In Cancer Care Market Share by Application: 2021 VS 2028
Figure 6. Diagnostics Case Studies
Figure 7. Personalized Medicine Case Studies
Figure 8. Drug Discovery Case Studies
Figure 9. Development Case Studies
Figure 10. Research Case Studies
Figure 11. Genomics In Cancer Care Report Years Considered
Figure 12. Global Genomics In Cancer Care Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Genomics In Cancer Care Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Genomics In Cancer Care Market Share by Region: 2021 VS 2028
Figure 15. Global Genomics In Cancer Care Market Share by Players in 2021
Figure 16. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2021
Figure 18. North America Genomics In Cancer Care Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Genomics In Cancer Care Market Size Market Share by Type (2017-2028)
Figure 20. North America Genomics In Cancer Care Market Size Market Share by Application (2017-2028)
Figure 21. North America Genomics In Cancer Care Market Size Share by Country (2017-2028)
Figure 22. United States Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Genomics In Cancer Care Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Genomics In Cancer Care Market Size Market Share by Type (2017-2028)
Figure 26. Europe Genomics In Cancer Care Market Size Market Share by Application (2017-2028)
Figure 27. Europe Genomics In Cancer Care Market Size Share by Country (2017-2028)
Figure 28. Germany Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Genomics In Cancer Care Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Genomics In Cancer Care Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Genomics In Cancer Care Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Genomics In Cancer Care Market Size Share by Region (2017-2028)
Figure 38. China Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Genomics In Cancer Care Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Genomics In Cancer Care Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Genomics In Cancer Care Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Genomics In Cancer Care Market Size Share by Country (2017-2028)
Figure 48. Mexico Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Genomics In Cancer Care Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Genomics In Cancer Care Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Genomics In Cancer Care Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Genomics In Cancer Care Market Size Share by Country (2017-2028)
Figure 54. Turkey Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Genomics In Cancer Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Illumina Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 58. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 59. Agilent Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 60. Roche Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 61. Cancer Genetics Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 62. Beckman Coulter Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 63. Bio-Rad Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 64. Danaher Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 65. Sigma Aldrich Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 66. Pacific Biosciences Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 67. Quest Diagnostics Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 68. Luminex Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 69. Oxford Gene Technology Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 70. PerkinElmer Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 71. Qiagen Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 72. GE Healthcare Revenue Growth Rate in Genomics In Cancer Care Business (2017-2022)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount